Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Connery

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Journal of Substance Use and Addiction Treatment|December 5, 2023
Rates and costs of drug testing practices for private payors in the outpatient setting in the United States, 2015-2019Rachel E Barenie, Brian T Bateman, Hilary S Connery, et al.
Addictive Behaviors|August 22, 2016
Perceived risk of heroin use among nonmedical prescription opioid usersVictoria R Votaw, Justine Wittenauer, Hilary S Connery, et al.
The American Journal on Addictions|September 9, 2020
Commentary: Proposed Model State Cannabis Laws to Reduce HarmsArthur Robin Williams, Kevin P Hill, Richard N Rosenthal, et al.
International Journal of Group Psychotherapy|March 7, 2024
Single-session Mentalization-based Treatment Group for Law Enforcement OfficersRobert P Drozek, Anthony W Bateman, Jonathan T Henry, et al.
Drug and Alcohol Dependence|October 19, 2019
Suicidal motivations reported by opioid overdose survivors: A cross-sectional study of adults with opioid use disorderHilary S Connery, Nadine Taghian, Jungjin Kim, et al.
Journal of Substance Abuse Treatment|January 31, 2017
Perceived barriers to smoking cessation among adults with substance use disordersR Kathryn McHugh, Victoria R Votaw, Francesca Fulciniti, et al.
Journal of Substance Abuse Treatment|August 14, 2014
Denial of urinalysis-confirmed opioid use in prescription opioid dependenceE Yvette Hilario, Margaret L Griffin, R Kathryn McHugh, et al.
Drug and Alcohol Dependence|May 17, 2014
Who benefits from additional drug counseling among prescription opioid-dependent patients receiving buprenorphine-naloxone and standard medical management?Roger D Weiss, Margaret L Griffin, Jennifer Sharpe Potter, et al.
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|September 26, 2019
Unrecognised self-injury mortality (SIM) trends among racial/ethnic minorities and women in the USAIan R H Rockett, Eric D Caine, Hilary S Connery, et al.
The Journal of Clinical Psychiatry|January 7, 2015
Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent populationKatherine A McDermott, Margaret L Griffin, Hilary S Connery, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Journal of Substance Use and Addiction Treatment|December 5, 2023
Rates and costs of drug testing practices for private payors in the outpatient setting in the United States, 2015-2019Rachel E Barenie, Brian T Bateman, Hilary S Connery, et al.
Addictive Behaviors|August 22, 2016
Perceived risk of heroin use among nonmedical prescription opioid usersVictoria R Votaw, Justine Wittenauer, Hilary S Connery, et al.
The American Journal on Addictions|September 9, 2020
Commentary: Proposed Model State Cannabis Laws to Reduce HarmsArthur Robin Williams, Kevin P Hill, Richard N Rosenthal, et al.
International Journal of Group Psychotherapy|March 7, 2024
Single-session Mentalization-based Treatment Group for Law Enforcement OfficersRobert P Drozek, Anthony W Bateman, Jonathan T Henry, et al.
Drug and Alcohol Dependence|October 19, 2019
Suicidal motivations reported by opioid overdose survivors: A cross-sectional study of adults with opioid use disorderHilary S Connery, Nadine Taghian, Jungjin Kim, et al.
Journal of Substance Abuse Treatment|January 31, 2017
Perceived barriers to smoking cessation among adults with substance use disordersR Kathryn McHugh, Victoria R Votaw, Francesca Fulciniti, et al.
Journal of Substance Abuse Treatment|August 14, 2014
Denial of urinalysis-confirmed opioid use in prescription opioid dependenceE Yvette Hilario, Margaret L Griffin, R Kathryn McHugh, et al.
Drug and Alcohol Dependence|May 17, 2014
Who benefits from additional drug counseling among prescription opioid-dependent patients receiving buprenorphine-naloxone and standard medical management?Roger D Weiss, Margaret L Griffin, Jennifer Sharpe Potter, et al.
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|September 26, 2019
Unrecognised self-injury mortality (SIM) trends among racial/ethnic minorities and women in the USAIan R H Rockett, Eric D Caine, Hilary S Connery, et al.
The Journal of Clinical Psychiatry|January 7, 2015
Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent populationKatherine A McDermott, Margaret L Griffin, Hilary S Connery, et al.
Pageof 6